<ѻýҕl>SABCS: Axillary RT as Good as Surgery in Breast Cancerѻýҕl> Radiation non-inferior to surgery after positive sentinel node Dec 07, 2018
<ѻýҕl>Low-Dose Tamoxifen Feasible Option in Breast Cancerѻýҕl> Women appear to prevent recurrence in early stage cancers with 5 mg dosing Dec 06, 2018
<ѻýҕl>ASH Poster Rounds: Obesity Impacts CLL Survival in Womenѻýҕl> Plus: New risk model predicts CLL survival; novel BTK inhibitor works after ibrutinib Dec 06, 2018
<ѻýҕl>Xeloda Disappoints in Early Triple-Negative Breast Cancerѻýҕl> No improvement after standard chemo, though subset may derive some benefit Dec 05, 2018
<ѻýҕl>T-DM1: A New Adjuvant Standard in High-Risk HER2+ Breast Ca?ѻýҕl> Substantial improvements in survival outcomes in KATHERINE trial Dec 05, 2018
<ѻýҕl>Cancer-VTE Trial Falls Shortѻýҕl> High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<ѻýҕl>Chemo-Free Tx Tops Best Option in Younger CLL Patientsѻýҕl> Improved overall survival and safety with ibrutinib-based therapy Dec 04, 2018
<ѻýҕl>Combination Regimen Extends PFS in Myelomaѻýҕl> Large benefit but relevance of comparator questioned Dec 04, 2018
<ѻýҕl>$2 Test Could Transform Sickle Cell Dx in Africaѻýҕl> May have applications in high-income countries as well Dec 04, 2018
<ѻýҕl>ASH Offers Early Look at Updated SCD Guidelinesѻýҕl> Experts formulated >50 recommendations on sickle cell disease Dec 03, 2018
<ѻýҕl>Add-On Drugs Could Boost Efficacy, Tolerability of CAR T-Cell Therapiesѻýҕl> Studies test addition of targeted agents, immunotherapy Dec 03, 2018
<ѻýҕl>SABCS: Translational Before It Was Coolѻýҕl> Growing, evolving while adhering to founding principles Dec 03, 2018
<ѻýҕl>CAR T-Cell Responses Prove Durable in ALL, DLBCLѻýҕl> Two studies demonstrate long-term control in relapsed/refractory disease Dec 01, 2018
<ѻýҕl>Cutting Chemo Cycles Feasible in Younger DLBCL Patientsѻýҕl> Patients, ages 18-60, fare well with four cycles of CHOP instead of six Dec 01, 2018
<ѻýҕl>Ibrutinib Alone Wins in Older CLL Patientsѻýҕl> Adding rituximab offered no added benefit Dec 01, 2018
<ѻýҕl>Younger High-Risk Women Benefit From Mammographyѻýҕl> Yields in 30-39 age group at high risk comparable to 40-49 group with average risk Nov 30, 2018
<ѻýҕl>Sneak Peek at Practice-Changing Research From ASH 2018ѻýҕl> "Big trials, big results," plus sickle cell disease and CAR T-cell therapies Nov 30, 2018
<ѻýҕl>Machine Learning Allows for Low-Dose Gadolinium Contrastѻýҕl> Minimal loss of resolution with 10% Gd dose Nov 30, 2018
<ѻýҕl>Morning Break: Measles Rebound; New FDA Warnings; Cancer Dx Scaresѻýҕl> Health news and commentary from around the Web gathered by the ѻýҕl staff Nov 30, 2018
<ѻýҕl>LMWH Prevails for VTE Prevention in Guidelineѻýҕl> ASH unveils first six chapters of comprehensive recommendations Nov 29, 2018
<ѻýҕl>FDA Approves Rituximab Biosimilar for NHLѻýҕl> Indications for front line or beyond, single agent or combination Nov 28, 2018
<ѻýҕl>YouTube Videos Often Mislead on Prostate Cancerѻýҕl> Misinformation, bias, and lack of balance in content Nov 28, 2018
<ѻýҕl>Digital Mammograms Show Vulnerability to Cyberattacksѻýҕl> Two out of three radiologists couldn't tell that images were manipulated Nov 28, 2018
<ѻýҕl>Implants May Still Hinder FFDM with Tomosynthesisѻýҕl> Presence of breast implants tied to decreased recall rates and cancer detection rates Nov 26, 2018
<ѻýҕl>Women 75 and Older Benefit from Annual Mammoѻýҕl> Significant number of invasive cancers found Nov 26, 2018
<ѻýҕl>No Surgery May Be Feasible in Gleason 9-10 Prostate Caѻýҕl> Study finds similar outcomes with two multimodal approaches Nov 23, 2018
<ѻýҕl>Highlights from Molecular Targets Symposiuimѻýҕl> Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<ѻýҕl>'My Cancer Free Life'? Not So Fastѻýҕl> Reality docuseries as a commercial for quack doc Nov 15, 2018
<ѻýҕl>AMA Urges Coverage for Added Breast Cancer Screeningѻýҕl> Resolution aimed at women with dense breasts Nov 13, 2018
<ѻýҕl>Regular Aspirin Use Tied to Reduction in HCC Riskѻýҕl> Significant benefit apparent after ≥5 years of use at average dose of at least 1.5 tablets/week Nov 13, 2018
<ѻýҕl>Simple Ovarian Cysts Hold No Cancer Riskѻýҕl> Malignancy extremely rare, don't need surveillance Nov 12, 2018
<ѻýҕl>AHA: Fish Oil, Vitamin D Not VITAL to Heart Healthѻýҕl> VITAL trial also showed no benefits for cancer incidence with both supplements Nov 10, 2018 video
<ѻýҕl>NCRI: Highlights from the Annual Conferenceѻýҕl> Prostate cancer tradeoffs, rising melanoma mortality, safer regimen for thyroid cancer Nov 05, 2018
<ѻýҕl>Morning Break: Dead-Butt Syndrome; Last Word on Cellphone Radiation; States vs Pharmaѻýҕl> Health news and commentary from around the Web gathered by the ѻýҕl staff Nov 02, 2018
<ѻýҕl>Pouch Creation a Winner After Total Gastrectomyѻýҕl> Meta-analysis reports better long-term functional outcomes, no greater perioperative morbidity Oct 30, 2018
<ѻýҕl>SGLT-2 for Stage 3 CKD; Opioids for CKD; Kidney Transplant Discard & Disabilitiesѻýҕl> Roundup of more top abstracts from Kidney Week 2018 Oct 30, 2018
<ѻýҕl>High-Dose Iron an Option for Maintenance Hemodialysisѻýҕl> High-dose noninferior to low-dose, required less erythropoiesis-stimulating agent Oct 28, 2018
<ѻýҕl>Ideal Timing of Post-Mohs Reconstructionѻýҕl> Waiting 7 days or more associated with reduced complications Oct 26, 2018
<ѻýҕl>Survival Bump with Palbociclib in HR+ Breast Cancerѻýҕl> But benefit limited to subgroups; study may have been underpowered Oct 25, 2018
<ѻýҕl>Group of Blood Pressure Drugs Linked to Lung Cancerѻýҕl> 14% higher likelihood in users of ACE inhibitors; causal relationship unproven Oct 25, 2018